Academic · Private company
Hoosier Cancer Research Network
Track this companyFree. Adds Hoosier Cancer Research Network to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown PrimaryPHASE2 · TERMINATED · started Feb 1, 2018ClinicalTrials.gov NCT03396471 · fetched Nov 12, 2026
- Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal CancerPHASE2 · COMPLETED · started May 28, 2015ClinicalTrials.gov NCT02375672 · fetched Nov 12, 2026
- First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial CarcinomaPHASE2 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01524991 · fetched Nov 12, 2026
- Doxorubicin + BIBF 1120 in Patients for Ovarian CancerPHASE1 · TERMINATED · started Nov 1, 2011ClinicalTrials.gov NCT01485874 · fetched Nov 12, 2026
- PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 MutationsPHASE2 · COMPLETED · started Feb 1, 2010ClinicalTrials.gov NCT01074970 · fetched Nov 12, 2026
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell CarcinomaPHASE1_PHASE2 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT01034631 · fetched Nov 12, 2026